Clin2
NCT06425380Possibly a fitRecruiting

Resistant potato starch for liver cirrhosis and confusion

Hepatic EncephalopathyCirrhosis

Part of Brain & nervous system, Digestive system, Hormones & metabolism clinical trials.

This study is testing whether a special type of starch (resistant potato starch) can help people with cirrhosis who have had episodes of confusion from liver problems. It may help by changing the bacteria in your gut, which could reduce the risk of future confusion episodes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
11 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You have been diagnosed with cirrhosis (scarring of the liver).
  • You have had at least one episode of confusion or drowsiness caused by liver problems (overt hepatic encephalopathy) in the past year.
  • You have not been in the hospital or taken antibiotics (except rifaximin) in the last 4 weeks.
  • You have not taken lactulose, a medicine for liver-related confusion, in the last 4 weeks.
  • You have not had more than one alcoholic drink per week or used any illicit drugs in the last month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07528690Not yet recruiting· Phase 2
Stool bacteria transplant for brain fog in liver disease

This study tests whether delivering healthy bacteria from a donor's stool (called a microbiota transplant) through a capsule can help people with cirrhosis and a history of hepatic encephalopathy. The goal is to improve brain function and reduce the risk of further confusion episodes.

West Haven, Connecticut
NCT06538077Recruiting· Phase 4
BCAA vs. Rifaximin to Prevent Recurrent Hepatic Encephalopathy

This trial compares two treatments—BCAA supplements and rifaximin—to see which is better at preventing another episode of confusion or coma in people with cirrhosis who have already had one. If you qualify, you would receive one of these treatments for several months.

Chandigarh
NCT06464952Recruiting
Prebiotics for PTSD and cirrhosis

This trial tests if a prebiotic supplement can improve gut health and PTSD symptoms in people with cirrhosis and PTSD. It aims to see if changing the gut microbiome can help both conditions.

Richmond, Virginia
NCT04073290Recruiting· Phase 4
Rifaximin and lactulose to prevent confusion after TIPS

This trial studies whether taking rifaximin plus lactulose can prevent a brain problem called hepatic encephalopathy (confusion) after TIPS, a procedure to reduce pressure in the liver. It may help people who are having TIPS planned and are at risk of this complication.

Leuven
NCT07454408Not yet recruiting· Phase 1/Phase 2
Healthy bacteria transfer for confusion after liver shunt

This study tests whether giving a fecal microbiota transplant (FMT) – putting carefully screened donor bacteria into your colon – can help prevent repeated episodes of confusion and memory problems (hepatic encephalopathy) that can happen after a liver procedure called TIPS. The goal is to improve your thinking and quality of life by restoring healthy gut bacteria.

Xi’an, Shanxi
NCT07683936Recruiting· Early Phase 1
Fecal transplant for brain issues after liver procedure

This trial tests if transferring healthy bacteria into your gut (fecal microbiota transplant) can help people who still get confusion episodes (hepatic encephalopathy) even after a TIPS procedure and while on standard medications like lactulose and rifaximin.

Xi'an

Hear when a new Hepatic Encephalopathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.